MKI67 and neoplasm: No statistically significant differences were observed between low SMI and normal SMI patients in terms of menopausal status, histologic type, molecular subtype, tumor grade, Ki-67 index, clinical T and N stage, clinical TNM stage, or neoadjuvant treatment regimens (all p > 0.05).